Related Experiment Video
Updated: Mar 10, 2026
Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Evaluating the benefits of high-dose statin preloading in ST-segment elevation myocardial infarction management:
Bernardo Resende1, Emídio Mata2, Tomás Carlos1
1Cardiology Department, Unidade Local de Saúde de Coimbra, Coimbra.
Insights
High-dose statin loading before primary percutaneous coronary intervention (PCI) in ST-segment elevation myocardial infarction (STEMI) patients improves coronary reperfusion and reduces mortality. This meta-analysis highlights the potential benefits of pre-PCI statin therapy.
Area of Science:
- Cardiology
- Pharmacology
Background:
- ST-segment elevation myocardial infarction (STEMI) requires urgent reperfusion for optimal outcomes.
- Statins may mitigate ischemia-reperfusion injury via pleiotropic effects.
- Guidelines have varied on recommending high-intensity statins before percutaneous coronary intervention (PCI).
Purpose of the Study:
- To systematically review and meta-analyze randomized controlled trials (RCTs).
- To evaluate high-dose statin loading before primary PCI in STEMI patients.
- To assess effects on coronary reperfusion and clinical outcomes.
Main Methods:
- Searched CENTRAL, EMBASE, and PubMed for RCTs comparing high-dose statin preloading versus placebo/no statin in STEMI patients undergoing primary PCI.
- Primary outcome: post-PCI Thrombolysis In Myocardial Infarction (TIMI) flow grade 3.
- Secondary outcomes: all-cause mortality and ST-segment resolution; analyzed using random-effects models.
Main Results:
- Nine RCTs involving 1862 patients were analyzed.
- High-dose statin preloading significantly increased the likelihood of achieving post-PCI TIMI flow grade 3 (OR: 1.52).
- Associated with reduced all-cause mortality (OR: 0.59), but no significant difference in ST-segment resolution.
Conclusions:
- High-dose statin loading before primary PCI in STEMI patients is linked to improved coronary reperfusion.
- This strategy appears to reduce all-cause mortality.
- Findings underscore the potential clinical value of pre-PCI statin therapy in STEMI management.
Introduction:
ST-segment elevation myocardial infarction (STEMI) is a life-threatening condition needing urgent reperfusion, with better outcomes linked to optimal myocardial perfusion. Statins may reduce ischemia-reperfusion injury through pleiotropic effects. While the 2019 European Society of Cardiology (ESC) Dislipidemia Guidelines recommended high-intensity statins before percutaneous coronary intervention (PCI), this was not included in the 2023 ESC or 2025 ACC/AHA/ACEP/NAEMSP/SCAI ACS Guidelines.
Objective:
To evaluate the effect of high-dose statin loading before primary PCI in improving coronary reperfusion and clinical outcomes in STEMI patients through a systematic review and meta-analysis of randomized controlled trials (RCTs).
Methods:
On June 2025, CENTRAL, EMBASE, and PubMed were searched for RCTs comparing high-dose statin preloading with placebo or no statin in STEMI patients undergoing primary PCI. The primary outcome was post-PCI thrombolysis in myocardial infarction (TIMI) flow grade 3. Secondary outcomes included all-cause mortality and greater than or equal to 50% ST-segment resolution. Data were pooled using random-effects models, reporting odds ratios (OR) with 95% confidence intervals (CIs).
Results:
Nine RCTs with 1862 patients were included. High-dose statin preloading significantly increased the likelihood of achieving post-PCI TIMI flow grade 3 (OR: 1.52, 95% CI: 1.06-2.20). It was also associated with a reduction in all-cause mortality (OR: 0.59, 95% CI: 0.36-0.98). No significant difference was observed in greater than or equal to 50% ST-segment resolution (OR: 1.04, 95% CI: 0.71-1.50).
Conclusion:
High-dose statin loading before primary PCI in STEMI patients seems to be associated with improved coronary reperfusion and reduced all-cause mortality. These findings offer timely and clinically relevant insight, reminding the cardiovascular community of the potential value of this therapeutic.
More Related Videos
04:30A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
Related Concept Videos
01:28Acute Coronary Syndrome IV: Interprofessional Care
01:26Atherosclerosis III: Management
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
01:26Angina IV: Management
01:30Acute Coronary Syndrome I: Introduction
01:20Angina V: Nursing Management